Shares of Protalix BioTherapeutics Inc (PLX) are trading down .04 to 5.22.? The stock is trading in the middle of the 52-week range.
Today paper traded the PLX May/Nov 5 call spread 2,000 times for .40.? The ADV is 204.? The open interest is just over 2,000 contracts in May and less than 200 in Nov.
The trade looks like a covered call writer closing for near parity and reselling the Nov 5s.
?30-day implied volatility is 44%.?? 10-day implied volatility is 18%.? 30-day implied volatility is trading above the 10-day historical volatility.
Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx.